Free Trial

Fonar (NASDAQ:FONR) Shares Cross Above 200-Day Moving Average - Here's Why

Fonar logo with Medical background

Fonar Corporation (NASDAQ:FONR - Get Free Report)'s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $14.29 and traded as high as $16.18. Fonar shares last traded at $16.00, with a volume of 50,981 shares traded.

Analyst Ratings Changes

Separately, Wall Street Zen lowered shares of Fonar from a "strong-buy" rating to a "buy" rating in a research note on Friday.

View Our Latest Stock Report on Fonar

Fonar Stock Performance

The business's 50 day moving average is $14.57 and its 200-day moving average is $14.29. The stock has a market cap of $99.20 million, a price-to-earnings ratio of 12.80 and a beta of 1.00.

Fonar (NASDAQ:FONR - Get Free Report) last released its quarterly earnings results on Thursday, May 15th. The medical equipment provider reported $0.37 earnings per share (EPS) for the quarter. Fonar had a net margin of 8.19% and a return on equity of 5.31%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of FONR. Bridgeway Capital Management LLC grew its position in shares of Fonar by 1.2% during the fourth quarter. Bridgeway Capital Management LLC now owns 80,035 shares of the medical equipment provider's stock worth $1,212,000 after buying an additional 945 shares in the last quarter. Empowered Funds LLC boosted its holdings in Fonar by 7.7% in the first quarter. Empowered Funds LLC now owns 21,139 shares of the medical equipment provider's stock valued at $296,000 after purchasing an additional 1,504 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Fonar by 0.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 376,678 shares of the medical equipment provider's stock valued at $5,703,000 after purchasing an additional 2,149 shares in the last quarter. Money Concepts Capital Corp boosted its holdings in Fonar by 1.2% in the first quarter. Money Concepts Capital Corp now owns 406,296 shares of the medical equipment provider's stock valued at $5,692,000 after purchasing an additional 4,719 shares in the last quarter. Finally, Linden Thomas Advisory Services LLC boosted its holdings in Fonar by 16.5% in the first quarter. Linden Thomas Advisory Services LLC now owns 34,054 shares of the medical equipment provider's stock valued at $477,000 after purchasing an additional 4,818 shares in the last quarter. Institutional investors and hedge funds own 50.64% of the company's stock.

About Fonar

(Get Free Report)

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fonar Right Now?

Before you consider Fonar, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fonar wasn't on the list.

While Fonar currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines